Odyssey Therapeutics Inc.
ODTX | NASDAQ
$19.54
-$0.29 (-1.46%)
At close: Oct 30, 2026, 4:00 PM ET
$19.54
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:18 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Revenue | 2.98M |
Cost of Revenue | n/a |
Gross Profit | 2.98M |
Operating Income | -161.16M |
Interest Income | 6.35M |
Pretax Income | -149.57M |
Net Income | -148.65M |
Selling & General & Admin | 37.52M |
Research & Development | 126.62M |
Other Expenses | n/a |
Operating Expenses | 164.13M |
Interest Expense | 17K |
Selling & Marketing Expenses | n/a |
Cost & Expenses | 164.13M |
Income Tax Expense | -927K |
Shares Outstanding (Basic) | 27.56M |
Shares Outstanding (Diluted) | 27.56M |
EPS (Basic) | -5.39 |
EPS (Diluted) | -5.39 |
EBITDA | -144.65M |
EBIT | -149.56M |
Depreciation & Amortization | 4.91M |
Add to Watchlist
Select watchlists to add or remove ODTX